Literature DB >> 3155362

The toxicity of disulphides to isolated hepatocytes and mitochondria.

S D Jatoe1, V Lauriault, L G McGirr, P J O'Brien.   

Abstract

The disulfide metabolites of thiono-sulfur drugs were found to be about 50 to 100 times more toxic to isolated rat hepatocytes than the corresponding parent drugs. The order of decreasing cytotoxicity for the disulfide metabolites was disulfiram greater than propylthiouracil disulfide greater than formamidine disulfide greater than phenylthiourea disulfide greater than thiobenzamide disulfide greater than cystamine. Depletion of intracellular GSH levels preceded cytotoxicity. GSH could be restored and cytotoxicity averted by adding the thiol reducing dithiothreitol. Depletion of GSH with diethylmaleate potentiated the toxicity of disulfides 3 to 4-fold confirming the protective role of GSH in disulfide toxicity. The toxicity of disulfiram was increased 4-fold in cells pretreated with ATP (0.8 mM) to effect a transient increase in cytosolic Ca2+ suggesting an impairment of Ca2+ homeostasis by the toxicant. Disulfiram (200 microM) rapidly depleted hepatocyte ATP levels within 15 minutes which suggests that ATP production is inhibited. The disulfide effectiveness at causing mitochondrial Ca2+ release was similar to their effectiveness at inducing hepatocyte cytotoxicity. These results suggest that hepatocyte toxicity is the result of oxidative inactivation of membrane protein thiols that regulate intracellular Ca2+ homeostasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3155362     DOI: 10.1515/dmdi.1988.6.3-4.395

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  2 in total

1.  Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.

Authors:  Noël J-M Raynal; Justin T Lee; Youjun Wang; Annie Beaudry; Priyanka Madireddi; Judith Garriga; Gabriel G Malouf; Sarah Dumont; Elisha J Dettman; Vazganush Gharibyan; Saira Ahmed; Woonbok Chung; Wayne E Childers; Magid Abou-Gharbia; Ryan A Henry; Andrew J Andrews; Jaroslav Jelinek; Ying Cui; Stephen B Baylin; Donald L Gill; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

2.  Post hoc study to investigate the potential causes of poor quality of cardiovascular medicines collected in sub-Saharan countries.

Authors:  Philippe-Henri Secretan; Marie Antignac; Najet Yagoubi; Mélisande Bernard; Marie Cécile Perier; Jean Laurent Takombe; Dadhi Balde; Roland N'Guetta; Méo Stéphane Ikama; Patrice Zabsonre; Abdallahi Sidi Aly; Xavier Jouven; Bernard Do
Journal:  BMJ Open       Date:  2020-11-09       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.